alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                           5,240
<SECURITIES>                                         0
<RECEIVABLES>                                   28,386
<ALLOWANCES>                                     (800)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                38,912
<PP&E>                                         355,895
<DEPRECIATION>                               (146,458)
<TOTAL-ASSETS>                                 306,030
<CURRENT-LIABILITIES>                           31,151
<BONDS>                                        262,375
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           119
<OTHER-SE>                                      11,655
<TOTAL-LIABILITY-AND-EQUITY>                   306,030
<SALES>                                        166,351
<TOTAL-REVENUES>                               166,351
<CGS>                                           74,008
<TOTAL-COSTS>                                   74,008
<OTHER-EXPENSES>                               101,434
<LOSS-PROVISION>                                   848
<INTEREST-EXPENSE>                              23,048
<INCOME-PRETAX>                               (39,537)
<INCOME-TAX>                                       375
<INCOME-CONTINUING>                           (39,912)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (39,912)
<EPS-PRIMARY>                                   (3.45)
<EPS-DILUTED>                                   (3.45)
        

</TABLE>
[Federal Register Volume 66, Number 31 (Wednesday, February 14, 2001)]
[Notices]
[Pages 10321-10322]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-3750]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated September 25, 2000, and published in the Federal 
Register on October 3, 2000, (65 FR 59018), Chattem Chemicals, Inc., 
3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                            Drug                               Schedule
------------------------------------------------------------------------
N-Ethylamphetamine (1475)...................................          I
4-Methoxyamphetamine (7411).................................          I
2,5-Dimethoxyamphetamine (7396).............................          I
Difenoxin (9168)............................................          I
Methylphenidate (1724)......................................         II
Pentobarbital (2270)........................................         II
Secobarbital (2315).........................................         II
Diphenoxylate (9170)........................................         II
Hydrocodone (9193)..........................................         II
------------------------------------------------------------------------

    The firm plans to bulk manufacture the listed controlled substances 
to produce products for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Chattem Chemicals, Inc. to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Chattem Chemicals, 
Inc. to ensure that the company's registration is consistent with the 
public interest. This investigation included inspection and testing of 
the company's physical security systems, verification of the

[[Page 10322]]

company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 823 
and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office 
of Diversion Control, hereby orders that the application submitted by 
the above firm for registration as a bulk manufacturer of the basic 
classes of controlled substances listed above is granted.

    Dated: January 25, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-3750 Filed 2-13-01; 8:45 am]
BILLING CODE 4410-09-M
[Federal Register Volume 66, Number 32 (Thursday, February 15, 2001)]
[Notices]
[Page 10506]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-3817]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, a 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.


    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel.
    Date: March 16, 2001.
    Time: 8 a.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ramada Inn, 1775 Rockville Pike, Rockville, MD 20852.
    Contact Person: Richard J Bartlett, PhD, Scientific Review 
Administrator, National Institute of Arthritis and Musculoskeletal 
and Skin Diseases, Natcher Bldg./Bldg. 45, Room 5As37B, (301) 594-
4952.


(Catalogue of Federal Domestic Assistance Program No. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)

    Dated: February 8, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-3817 Filed 2-14-01; 8:45 am]
BILLING CODE 4140-01-M
#### UNITED STATES of America, Plaintiff-Appellee v. Alejandro CONTRERAS-MENESES, also known as Alejandro Contreras-Ramirez, Defendant-Appellant.

No. 13-40519

Summary Calendar.

United States Court of Appeals, Fifth Circuit.

April 30, 2014.

Renata Ann Gowie, Assistant U.S. Attorney, U.S. Attorney’s Office, Houston, TX, for Plaintiff-Appellee.

Juan P. Reyna, Corpus Christi, TX, for Defendant-Appellant.

Before REAVLEY, JONES, and PRADO, Circuit Judges.

PER CURIAM: *

The attorney appointed to represent Alejandro Contreras-Meneses has moved for leave to withdraw and has filed a brief in accordance with *Anders v. California,*386 U.S. 738, 87 S.Ct. 1396, 18 L.Ed.2d 493 (1967), and *United States v. Flores,*632 F.3d 229 (5th Cir.2011). Contreras-Meneses has not filed a response. We have reviewed counsel’s brief and the relevant portions of the record reflected therein. We concur with counsel’s assessment that the appeal presents no nonfrivolous issue for appellate review. Accordingly, counsel’s motion for leave to withdraw is GRANTED, counsel is excused from further responsibilities herein, and the APPEAL IS DISMISSED. *See*5th Cir. R. 42.2.

*

 Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.
Exhibit 10.2REGISTRATION RIGHTS AGREEMENT          This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 24, 2006 is made andentered into between ZILA, INC., a Delaware corporation (the “Company”), and BLACK DIAMONDCOMMERCIAL FINANCE, L.L.C. (the “Investor”).          WHEREAS, the Company and the Investor have entered into that certain Credit Agreement, datedas of the date hereof (the “Credit Agreement”);          WHEREAS, pursuant to the terms of, and in partial consideration for, the Investor’s agreementto enter into the Credit Agreement, the Company has issued to the Investor a Warrant of even dateherewith, exercisable from time to time during the period commencing on the date hereof and endingon the fifth anniversary of the date hereof (the “Warrant”) for the purchase of an aggregate of1,200,000 shares of common stock of the Company, par value $.001 per share (the “Common Stock”), ata price specified in such Warrant;          WHEREAS, pursuant to the terms of, and in partial consideration for, the Investor’s agreementto enter into the Credit Agreement, the Company has agreed to provide the Investor with certainregistration rights with respect to the Registrable Securities (as defined below);          NOW, THEREFORE, in consideration of the premises, the representations, warranties, covenantsand agreements contained herein, in the Warrant and in the Credit Agreement, and for other good andvaluable consideration, the receipt and sufficiency of which are hereby acknowledged, intending tobe legally bound hereby, the parties hereto agree as follows:ARTICLE I.
[Federal Register Volume 67, Number 1 (Wednesday, January 2, 2002)]
[Notices]
[Pages 86-87]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-32160]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel.
    Date: December 21, 2001.
    Time: 8:30 am to 3:00 pm.
    Agenda: To review and evaluate grant applications.
    Place: Natcher Building, 45 Center Drive, Conference Rooms E1/
E2, Bethesda, MD 20892. (Telephone Conference Call)
    Contact Person: Tracy A. Shahan, PhD, Scientific Review 
Administrator, National Institute of Arthritis and Musculoskeletal 
and Skin Diseases, Natcher Building, MSC 6500,

[[Page 87]]

45 Center Drive, 5AS-25H, Bethesda, MD 20892, (301) 594-4952.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel.
    Date: December 21, 2001.
    Time: 3:30 pm to 4:30 pm.
    Agenda: To review and evaluate grant applications.
    Place: Natcher Building, 45 Center Drive, Conference Rooms E1/
E2, Bethesda, MD 20892. (Telephone Conference Call)
    Contact Person: Tracy A. Shahan, PhD, Scientific Review 
Administrator, National Institute of Arthritis and Musculoskeletal 
and Skin Diseases, Natcher Building, MSC 6500, 45 Center Drive, 5AS-
25H, Bethesda, MD 20892, (301) 594-4952.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)

    Dated: December 20, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-32160 Filed 12-31-01; 8:45 am]
BILLING CODE 4140-01-M
<PAGE>

                    COMMERCIAL NATIONAL FINANCIAL CORPORATION

                 CERTIFICATION OF QUARTERLY REPORT ON FORM 10-Q
                                       OF
                    COMMERCIAL NATIONAL FINANCIAL CORPORATION

                FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2002

The undersigned are the Chief Executive Officer and the Chief Financial Officer
of Commercial National Financial Corporation (the "Registrant"). This
Certification is made pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
This Certification accompanies the Quarterly Report on Form 10-Q of the
Registrant for the quarterly period ended September 30, 2002.

We certify that such Quarterly Report on Form 10-Q fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934
and that the information contained in such 10-Q Report fairly presents, in all
material respects, the financial condition and results of operations of the
Registrant.

This Certification is executed as of November 13, 2002.

                                           /s/ Jeffrey S. Barker
                                           ------------------------------
                                           Jeffrey S. Barker
                                           President and Chief Executive Officer

                                           /s/ Patrick G. Duffy
                                           ------------------------------
                                           Patrick G. Duffy
                                           Executive Vice President and
                                           Chief Financial Officer
In the

Court of Appeals

Second Appellate District of Texas

at Fort Worth

No. 02-20-00219-CV

VAN LE AND DUNG TRAN, Appellants

V.

QUYEN NGUYEN, Appellee

§

§

§

§

On Appeal from the 393rd District Court

of Denton County (19-7206-393)

May 13, 2021

Per Curiam Memorandum Opinion

JUDGMENT

This court has considered the record on appeal in this case and holds that the 

appeal should be dismissed. It is ordered that the appeal is dismissed for want of 

prosecution.

SECOND DISTRICT COURT OF APPEALS

PER CURIAM
#### CHICAGO, R. I. & P. R. CO. v. EXCISE BOARD OF POTTAWATOMIE COUNTY.

No. 25581.

Jan. 8, 1935.

W. R. Bleakmore, W. L. Farmer, John Barry, and Robert E. Lee, for plaintiff in error.

Clarence Tankersley, for defendant in error.

PER CURIAM.

In accordance with the opinion in the case of Lowden et al. v. Excise Board of Pittsburg County, No. 25479, 170 Okla. 181, 40 P. (2d) 16, this cause is reversed and remanded, with directions to the Court of Tax Review to enter judgment in accordance with the stipulation as follows ;

> “It is stipulated and agreed that since this appeal was perfected the questions of law raised in each assignment of error have been determined by this court as contended for by the plaintiff in error that the issues involved in this appeal are controlled by the decision of this court in the case of in cause No. 25203, entitled School District No. 33, Choctaw County, Oklahoma, v. A. W. Trice et al., opinion filed in this court on February 16, 1934, and petition for rehearing later denied (168 Okla. 344, 32 P. [2d] 906).

> “It is agreed on account of the decision in said Choctaw County Case, supra, the judgment of the Court of Tax Review in the case at_bar is error and this cause should be reversed.

> “It is therefore agreed that said cause may be reversed and remanded to the trial court, with directions to sustain each of the items of protest set up in the four assignments of error in this appeal upon the authority of the decision of this court in said Choctaw County Case, supra.”
#### UNITED STATES of America, Plaintiff-Appellee, v. Carlos SERRANO, Defendant-Appellant.

No. 09-50098.

United States Court of Appeals, Ninth Circuit.

Argued and Submitted Dec. 10, 2010.

Filed Dec. 16, 2010.

*184Jason Paul Gonzalez, Assistant U.S., Michael J. Raphael, Esquire, Assistant U.S., Office of the U.S. Attorney, Los Angeles, CA, Ellen Meltzer, Special Counsel, DOJ-U.S. Department of Justice, Washington, DC, for Plaintiff-Appellee.

Liliana Coronado, Esquire, Federal Public Defender, Kurt J. Mayer, Assistant Federal Public Defender, FPDCA-Federal Public Defender’s Office, Los Angeles, CA, for Defendant-Appellant.

Before: TROTT, WARDLAW, and IKUTA, Circuit Judges.

MEMORANDUM *

Though the district court erred in overruling defense counsel’s objection when the prosecutor asked Carlos Serrano during cross-examination whether Postal Service Inspector Kugel was “lying,” *United States v. Harrison,*585 F.3d 1155, 1158 (9th Cir.2009), the government has satisfied its burden of establishing harmlessness, *United States v. Hernandez,*109 F.3d 1450, 1453 (9th Cir.1997) (per curiam), by demonstrating that it is not “more probable than not that the alleged misconduct affected the jury’s verdict,” *United States v. Nobari,*574 F.3d 1065, 1082 (9th Cir.2009) (quoting *United States v. Simtob,*901 F.2d 799, 806 (9th Cir.1990)) (internal quotation marks omitted). First, the government provided ample evidence that Serrano knew that he was participating in a fraudulent transaction, *United States v. Weatherspoon,*410 F.3d 1142, 1151 (9th Cir.2005); *see also Nobari,*574 F.3d at 1082, including Serrano’s sworn statement, emails instructing him to make misrepresentations to the bank, documents in which Serrano certified the veracity of false information, and testimonial evidence *185that he employed aliases and opened a bank account for the sole purpose of depositing funds from the transaction.

Moreover, because Serrano responded to the government’s improper question by stating that Kugel was telling the truth, the question did not pit Serrano’s credibility against Kugel’s, a fact which further undercuts Serrano’s claim that the improper question was harmful. *See Harrison,*585 F.3d at 1159; *United States v. Combs,*379 F.3d 564, 573 (9th Cir.2004). Contrary to Serrano’s argument, the case cannot be reduced to a credibility contest between Serrano and Kugel as to the veracity of Serrano’s statement that he knew “from day one” that the transaction was suspicious, because the government needed only to establish that Serrano knew during the course of the transaction that he was participating in fraudulent activities. *See*18 U.S.C. §§ 371,1344(2).

Finally, the court advised the jury that it was the “sole and exclusive judge[ ] of the credibility of each of the witnesses called to testify in this case.” *See Harrison,*585 F.3d at 1159-60. The jury is presumed to have followed the court’s instructions. *See Zafiro v. United States,*506 U.S. 534, 540-41, 113 S.Ct. 933, 122 L.Ed.2d 317 (1993).

AFFIRMED.

*

 This disposition is not appropriate for publication and is not precedent except as provided by 9 th Cir. R. 36-3.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Energy

###### Federal Energy Regulatory Commission

          - [Docket No. CP01-30-001]

Take notice that on January 15, 2001, OkTex Pipeline Company (OkTex) filed tariff sheets to comply with the Commission's Order Approving Abandonments and Issuing Certificate issued on December 1, 2000 in Docket NO. CP01-30-000.

OkTex states that the tariff sheets reflect the adoption of the rates related to the facilities abandoned by ONEOK Midstream Pipeline, Inc. (Midstream) to service over the facilities by OkTex as authorized in Docket No. CP01-30-000. Pursuant to the above-mentioned order, OkTex will assure that there is no rate impact on the existing interruptible customers by including all discount arrangements previously negotiated by Midstream and its shippers.

OkTex states that copies of the filing have been mailed to all affected customers and state regulatory commissions.

                    Any person desiring to be heard or to protest said filing should file a petition to intervene or protest with the Federal Energy Regulatory Commission, 888 First Street, NE., Washington, DC 20426, in accordance with Section 385.211 of the Commission's Rules and Regulations. All such petitions or protests must be filed in accordance with Section 154.210 of the Commission's Regulations. Protests will be considered by the Commission in determining the appropriate action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must file a motion to intervene. Copies of this filing are on file with the Commission and are available for public inspection in the Public Reference Room. This filing may be viewed on the web at                     *http://www.ferc.fed.us/​online/​rims.htm*                     (call 202-208-2222 for assistance). Comments and protests may be filed electronically via the internet in lieu of paper. See 18 CFR 385.2001(a)(1)(iii) and the instructions on the Commission's web site at                     *http://www.ferc.fed.us/​efi/​doorbell.htm.*

Linwood A. Watson, Jr.,

Acting Secretary.

[FR Doc. 01-3806  Filed 2-14-01; 8:45 am]

BILLING CODE 6717-01-M
ROGER S. HARRIS

,

Appellant,

v.

STATE OF FLORIDA

,

Appellee

. IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO

FILE MOTION FOR REHEARING AND

DISPOSITION THEREOF IF FILED

CASE NO. 1D 16

- 0 154

________ _____________________/

Opinion filed July 12, 2016.

An appeal from an order of the Circuit Court for Columbia County

. Wesley R. Douglas , Judge

.

Roger S. Harris, pro se

, Appellant.

Pamela Jo Bondi, Attorney General, and Quentin Humphrey, Assistant Attor ney

General, Tallahassee , for Appellee.

PER CURIAM.

AFFIRMED.

LEWIS, WETHERELL, and RAY, JJ. CONCUR.